This site uses cookies. By using this site you agree to receiving cookies. View Policy.
Rather than investing and immediately receiving shares, in this round payments will be transferred directly to the company and shares issued at a future date. A convertible allows a company to raise funds without having to agree a valuation. For more information please view our FAQs.
FreeHand is a robotic surgical camera controller that provides rock-steady images and precise control saving time and improving outcomes. With regulatory approval in the EU, US and Japan, Freehand is fundraising to support sales growth.
Over 15 million keyhole surgeries are performed annually. Common procedures include appendectomies, gall bladder removal, hernia repair and cancer treatment. Most of these require an additional clinician in theatre to manually hold the camera the surgeon uses to see the operating field.
Anyone who has seen a shaky cell-phone video knows that holding objects steady for long periods of time is not something humans do well. Hand-held surgical cameras produce sub-optimal images with shake, drift and rotation. The patented FreeHand robotic camera controller provides a clear, rock steady image giving the surgeon full and precise control.
Studies show that FreeHand can REDUCE:
* Operating time by up to 20%
* Post-operative recovery time and complications
* Surgical training time
* Theatre head-count
Surgical robotics is one of the fastest-growing segments in MedTech, projected to reach $91.5B by 2025. FreeHand provides hospitals with an affordable, easy-to-use platform to realise the benefits of robotic assistance in operating rooms.
With the hiring of an experienced VP of Sales in May of 2019 and the launch of Freehand Panorama, the company now has hospitals and distributors signed up in the UK, Spain, Netherlands and Italy.
This investment will fund expansion of distributor base in Europe, Asia and Latin America, targeting over 12 million procedures annually.